Pamrevlumab inhibits posterior capsule opacification via selective CTGF/β-catenin axis modulation and collagen-1 suppression in primary pediatric LECs
- DOI
- 10.3897/pharmacia.73.e190953
- Published
- 2026-07-09
- Container
- Pharmacia
- Publisher
- Pensoft Publishers
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3897/pharmacia.73.e190953,
title = {Pamrevlumab inhibits posterior capsule opacification via selective CTGF/β-catenin axis modulation and collagen-1 suppression in primary pediatric LECs},
author = {Lely Retno Wulandari and Intan Kautsarani and Rofiqi Rofiq and Edwin Damar Prabowo and Hidayat Sujuti and Happy Kurnia Permatasari and Sri Winarsih},
year = {2026},
journal = {Pharmacia},
doi = {10.3897/pharmacia.73.e190953},
url = {https://doi.org/10.3897/pharmacia.73.e190953}
}RIS
TY - JOUR TI - Pamrevlumab inhibits posterior capsule opacification via selective CTGF/β-catenin axis modulation and collagen-1 suppression in primary pediatric LECs AU - Lely Retno Wulandari AU - Intan Kautsarani AU - Rofiqi Rofiq AU - Edwin Damar Prabowo AU - Hidayat Sujuti AU - Happy Kurnia Permatasari AU - Sri Winarsih PY - 2026 JO - Pharmacia DO - 10.3897/pharmacia.73.e190953 UR - https://doi.org/10.3897/pharmacia.73.e190953 ER -
APA
Wulandari, L. R., Kautsarani, I., Rofiq, R., Prabowo, E. D., Sujuti, H., Permatasari, H. K., & Winarsih, S. (2026). Pamrevlumab inhibits posterior capsule opacification via selective CTGF/β-catenin axis modulation and collagen-1 suppression in primary pediatric LECs. Pharmacia. https://doi.org/10.3897/pharmacia.73.e190953
Source records
- crossref · retrieved 2026-09-25T10:58:55.891Z